Global private equity and venture capital news and research

Germany anti-heart attack cryotherapy company nets €6.5m for Series A

7 May 2014

heart_lrgGermany cryotherapy business CryoTherapeutics has brought its Series A funding round to €6.5m thanks to new investment led by Peppermint Venture Partners.

KfW, NRW.BANK, Rainer Christine Asset Management and High-Tech Gruenderfonds also took part in the round for CryoTherapeutics, which has developed a system to help treat and prevent heart attacks.

Peppermint managing partner Joachim Rautter said, “We are very pleased to continue to support this exciting technology with a substantial injection of additional funding, to allow the company to accelerate its development programmes to achieve initial clinical validation for its cryotherapy technology.

“We believe the field of interventional cardiology will benefit from therapeutic technologies that do not require implantation of foreign materials inside coronary arteries, and we are very excited by the prospect that CryoTherapeutics’ technology can potentially offer for the treatment of atherosclerotic plaque.”

Peppermint is a Berlin-based venture capital firm which invests in young healthcare companies with a focus on medical devices, mainly within Europe.

Those businesses must have successfully demonstrated a first proof-of-concept for their technology, product or services to receive investment.

Copyright © 2014 AltAssets

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016